News
August 13, 2021
The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: As part of the FDA’s effort…
August 13, 2021
On Fri., Aug. 13, 2021, the Centers of Disease Control and Prevention’s Advisory Committee on Immunization Practices outlined clinical recommendations regarding an additional dose of…
The U.S. Food and Drug Administration today approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic sleep…
August 6, 2021
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, FDA announced that…
August 6, 2021
Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset…
August 5, 2021
The following quote is attributed to Susan Mayne, Ph.D., director of the Center for Food Safety and Applied Nutrition “The FDA is committed to ensuring…
August 4, 2021
Today, the U.S. Food and Drug Administration announced participation in several new collaborative communities aimed at addressing challenges in patient health care. Collaborative communities are…
August 3, 2021
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: In mid-July, the FDA…
July 30, 2021
The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA revised…
The following quote is attributed to Mitch Zeller, J.D., director of FDA’s Center for Tobacco Products “Today, the FDA issued a warning letter to a…
Latest Posts

